<< Read Full Article
<< Read Full Article
Tuesday's Analysts' Upgrades and Downgrades
CHANGE IN RATINGS
Accuray (ARAY Quote) initiated with Buy rating at Jefferies. Price target begins at $29 and 2007 EPS estimates set at $0.82.Express Scripts (ESRX Quote) upgraded to Buy rating from Neutral at UBS. Price target jumps to $99 from $77 and 2007 EPS estimates rise to $4.31 from $3.98.
Gilead (GILD Quote) was upgraded from Neutral to Buy at Merrill Lynch. $91 price target. Long-term growth prospects are improving for the HIV franchise, and new product launches could perform ahead of expectations.
Medimmune (MEDI Quote) was downgraded to Peer Perform at Bear Stearns. Upside could be limited over the next 6 to 12 quarters, unless the stock is taken over. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |
Connect with TheStreet